Showing results (21-30 of 554) with videos related to
Sort By:
Pageof 56
Haematologica|September 10, 2002
Idiotypic vaccination for B-cell malignancies as a model for therapeutic cancer vaccines: from prototype protein to second generation vaccinesPier Adelchi Ruffini, Sattva S Neelapu, Larry W Kwak, et al.Current Topics in Microbiology and Immunology|June 16, 2010
Identification of human idiotype-specific T cells in lymphoma and myelomaJinsheng Weng, Sattva S Neelapu, Alison F Woo, et al.Cancers|July 2, 2021
Early Survival Prediction Framework in CD19-Specific CAR-T Cell Immunotherapy Using a Quantitative Systems Pharmacology ModelAnna Mueller-Schoell, Nahum Puebla-Osorio, Robin Michelet, et al.Cancer Cell|September 22, 2023
A single-cell atlas of CD19 chimeric antigen receptor T cellsXubin Li, Jared Henderson, Max J Gordon, et al.Expert Opinion on Biological Therapy|December 8, 2006
BiovaxID: a personalized therapeutic cancer vaccine for non-Hodgkin's lymphomaSeung-Tae Lee, Yun-Fang Jiang, Keon-Uk Park, et al.Blood|September 8, 2012
Transcription and translation are primary targets of Pim kinase inhibitor SGI-1776 in mantle cell lymphomaQingshan Yang, Lisa S Chen, Sattva S Neelapu, et al.Oncotarget|December 15, 2015
Molecular evidence of Zn chelation of the procaspase activating compound B-PAC-1 in B cell lymphomaAloke Sarkar, Kumudha Balakrishnan, Jefferson Chen, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 26, 2016
Idelalisib Impacts Cell Growth through Inhibiting Translation-Regulatory Mechanisms in Mantle Cell LymphomaQingshan Yang, Lisa S Chen, Min Jin Ha, et al.Pharmacotherapy|January 13, 2017
Chimeric Antigen Receptor T Cells in Hematologic MalignanciesBrandon R Shank, Bryan Do, Adrienne Sevin, et al.Scientific Reports|February 4, 2017
Platelet activating factor-induced expression of p21 is correlated with histone acetylationElisabetta Damiani, Nahum Puebla-Osorio, Bree M Lege, et al.Pageof 56